Global Pricing Innovations

What does Global Pricing Innovations do?

GPI is a market leader in analytics and innovative solutions for biopharma pricing and market access. Founded in 2015 and headquartered London, GPI support price decision-making throughout the lifecycle and help the industry achieve day-to-day operational improvement and market access excellence.

How much does Global Pricing Innovations cost?

The supported pricing models for Global Pricing Innovations’ data are available by getting in contact with them via Datarade. Global Pricing Innovations offers free samples for individual data requirements. Get talking to a member of the Global Pricing Innovations team to receive custom pricing options, information about data subscription fees, and quotes for Global Pricing Innovations’ data offering tailored to your use case.

What kind of data does Global Pricing Innovations have?

Pharma Data and Healthcare Industry Leads Data

What data does Global Pricing Innovations offer?

Treatment costs: average cost to treat a patient per day/month/annum down to pack level price Price and Reimbursement: list and visible net pricing data with payer compensation and restrictions, at pack level across 90+ markets. Historical data across all markets, with an average of 5 years. HTA: decisions and drivers across 25 countries Regulatory: official labels, regulatory information, launch dates Policy and IRP: legislative updates impacting P&R

How does Global Pricing Innovations collect data?

Our data is gathered from hundreds of underlying public and private sources globally. Automatic collection of newly published information ensures the most up-to-date price and market access data. The disparate sources of data are then standardised to ensure analysis-ready data with seamless comparability across markets.

What’s Global Pricing Innovations’ data privacy policy?

GPI is committed to ensuring that your privacy is protected. Should we ask you to provide certain information by which you can be identified with when using our website, mobile and other applications owned and operated by GPI, then you can be assured that it will only be used in accordance with this privacy statement.

What are the best use cases for Global Pricing Innovations’ data?

Early Development – Evaluating Commercial Potential Our client was looking for a different set of inputs to justify price levels in price negotiation, as well as sense-checking the findings from more traditional pricing research such as payer and KOL interviews. GPI leveraged an in-house price model that considered analogue information, retrospective HTA outcomes, SoC and competitors to asses the relationship between HTA and pricing as well as provide insights into price positioning and an understanding of value drivers. Based on GPI’s model, the client gained an evidence-based insight into how HTA and prices may be linked. The findings from the analysis provided a clear outline of key analogue value – price relationships and helped our client to complete the strategic puzzle to position and optimise list prices and anticipate net pricing. Pre-Launch - Commercial Forecasting The project brief was to address several different forecasting needs to capture all aspects of a global product launch across multiple indications and patient groups. Our client was particularly looking to obtain a tool to address financial, market access as well as manufacturing forecasting needs across launch and beyond. GPI created a global commercial forecast model in Excel that was flexible to incorporate several indications, distinguish different patient groups and market requirements. Competitor assumption, market access programmes and pricing approaches were incorporated. The tool provided sales, revenues and demand modelling as well as scenario analyses with monthly and yearly outputs. The model provided our client with powerful insights to estimate sales and revenue, plan for demand and manufacturing. Model outputs were used for senior management reporting, budgeting, launch and manufacturing planning. Additionally, scenarios analysis helped to evaluate different commercial strategies. The model was flexible enough to be updated and adjust as launch progressed. Launch Finalize pricing policy/optimize launch Our client was launching a new drug in phase III in a crowded space and need reliable and timely insights to stay ahead of the market. Scope: 50 countries Using GPI pulse, the company was able to review all pricing, reimbursement, regulatory and market access insights for drugs already launched with same mechanism of action and indication. The client was able to determine the pricing and access landscape with detailed descriptions of gold standards and benchmarks against peers and best practice companies. Client had a robust understanding of the data and arguments presented and payer decisions at the click of the button. The insights enabled decision making and helped the client understand pricing, endpoints, comparators, payer interests and cost of each treatment option saving time and cost of a consulting engagement.